Biocon gains on getting EU GMP certification for manufacturing facility in Bangalore

05 Jul 2018 Evaluate

Biocon is currently trading at Rs. 634.55, up by 6.40 points or 1.02% from its previous closing of Rs. 628.15 on the BSE.

The scrip opened at Rs. 636.70 and has touched a high and low of Rs. 639.30 and Rs. 632.00 respectively. So far 1505 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 695.00 on 05-Jun-2018 and a 52 week low of Rs. 305.00 on 10-Jul-2017.

Last one week high and low of the scrip stood at Rs. 639.70 and Rs. 604.40 respectively. The current market cap of the company is Rs. 37689.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 20.92% and 18.41% respectively.

Biocon has received the European Union (EU) Good Manufacturing Practice (GMP) certification for its Sterile Drug Product manufacturing facility in Bangalore, which was inspected by the European agencies in March 2018. This facility is used for the manufacture of the company’s portfolio of biosimilars.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

365.25 -1.15 (-0.31%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×